• ##navigation.register##
  • ##navigation.login##
    • en
    • uz
    • ru
  • en
  • uz
  • ru
##navigation.register## ##navigation.login##
  • Joriy
  • ##navigation.archives##
    • ##about.aboutContext##
    • ##about.submissions##
    • ##common.editorialMasthead##
    • ##manager.setup.privacyStatement##
    • ##about.contact##
Joriy ##navigation.archives##
##about.aboutContext## ##about.submissions## ##common.editorialMasthead## ##manager.setup.privacyStatement## ##about.contact##
  1. ##common.homepageNavigationLabel##
  2. ##common.search##

##common.search##

##search.advancedFilters##
##search.dateFrom##
##search.dateTo##

##search.searchResults##

##search.searchResults.foundSingle##
  • GENETIC ASPECTS OF THE RISK OF DEVELOPMENT MISCARRIAGE AFTER IVF

    Aslonova M.J.

    The article presents the results of molecular genetic studies of the gene of the folate cycle of protein synthesis - methionine synthase reductase (MTRR) in women with PD in the Uzbek population. 130 pregnant women aged 21 to 38 were examined. All pregnant women underwent clinical and laboratory, instrumental, functional, molecular genetics, and statistical studies. The main group consisted of 100 women with miscarriage after IVF.
    The results of clinical and molecular genetic studies have shown that in patients with identified non-functional genotypes A / G A66G (Ile22Met) of the MTRR gene, there is a risk of miscarriage in women after IVF, which amounted to 22% of cases. (χ2=15.03 p<0.0001; OR=32.4; 95%CI 1.97-535.6). Allelic variants of G and the association of polymorphisms of heterozygous A/G genotypes of the MTRR gene are significant prognostic criteria for the risk of miscarriage in women with IVF.All pregnant women after IVF need to continue taking methylfolate (Folinexis), NMH (flenox 0.4 for ME) and micronized progesterone Biogest 400 rectally, proper nutrition, constant activation.

    11-16
    08-08-2025
    Davomini o‘qing
##navigation.items##

Ma'lumot

  • ##navigation.infoForReaders##
  • Mualliflar uchun
  • Kutubxonachilar uchun

So'nggi nashrlar

  • Atom logotipi
  • RSS2 logotipi
  • RSS1 logotipi
TNMU Publishing

Biz tibbiyotning rivojlanishini tezlashtirish va jamiyat salomatligini yaxshilash uchun tadqiqotchilar, bilim va texnologiyalarni birlashtiramiz.

 

Navigatsiya

Bosh sahifa
Jurnallar
Konferensiyalar
Mualliflar
Taqrizchilar
Nashriyot xizmatlari

Madad

Ijodkor qoidalari
Nashr axloqi
Biz haqimizda
Savol-javob
Qayta aloqa

Kontaktlar

 
O‘zbekiston, Toshkent,,
Olmazor tumani, Shifokorlar ko‘chasi, 21-uy
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
##user.login##
Central Asian Journal of Medicine
##user.login##
* ##common.required##
* ##common.required##
##user.login.forgotPassword##
##user.login.rememberUsernameAndPassword##
##user.login.registerNewAccount##